Our portfolio companies
We seek to invest in privately held companies with best-in-class management teams to help accelerate their growth.
![Athira [from website]](https://vikingglobal.com/wp-content/uploads/2023/02/Athira-from-website-1.png)
![Atyr [from website]](https://vikingglobal.com/wp-content/uploads/2023/02/Atyr-from-website.png)
![Joyn Bio [from online]](https://vikingglobal.com/wp-content/uploads/2023/04/Joyn-Bio-from-online-1.png)
![Zentalis [from online]](https://vikingglobal.com/wp-content/uploads/2023/02/Zentalis-from-online-1.png)
Joyn Bio
Synthetic biology company created as a joint venture between Bayer and Ginkgo Bioworks, focused on genetically engineering naturally occurring microbes to improve farmers’ crop yields, crop quality, and cost structure.
Joyn’s assets were acquired by Ginkgo in 2022 in exchange for rights to receive commercialization royalty payments.
| Investment status | Year invested |
|---|---|
| Active | 2017 |
As of September 30, 2024.
The portfolio companies identified on this page represent substantially all investments made as part of Viking’s private equity strategies by Viking clients that pursue Viking’s designated private equity strategy or Viking’s hybrid public-private equity strategy as of the date indicated herein. As a result, the specific portfolio companies identified are not representative of all investments made by Viking and it should not be assumed that any investment in the identified portfolio companies was or will be profitable. No representation is made that the individual portfolio companies identified herein remain current recommendations or current holdings. Actual holdings will vary for each Viking client and there is no guarantee that a particular Viking client will hold an interest in any or all of the identified portfolio companies. For avoidance of doubt, notwithstanding the use of the term “portfolio companies” to refer to investments, certain investments made as part of Viking’s private equity strategies may be publicly traded and may in certain instances be freely tradeable. Refer to the User Agreement for additional terms and conditions.